Published in
Elsevier, European Journal of Cancer, 18(49), p. 3821-3830
DOI: 10.1016/j.ejca.2013.09.026
Links
Tools
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer
Journal article published in 2013 by
R. J. van Soest,
M. E. van Royen 
,
E. S. de Morrée,
J. M. Moll,
W. Teubel,
E. A. C. Wiemer ,
R. H. J. Mathijssen,
R. de Wit,
W. M. van Weerden
,
E. S. de Morrée,
J. M. Moll,
W. Teubel,
E. A. C. Wiemer ,
R. H. J. Mathijssen,
R. de Wit,
W. M. van Weerden
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 